OtoGlobal Health
At OtoGlobal,
We revolutionize the standard of care for pediatric hearing loss globally with our novel, low-cost, simple-to-use screening device.
The Problem
Unidentified hearing loss is the most common and significant disability impacting pediatric development.
Infants in low-resource setting do not have access to timely screening as traditional screening devices are expensive and require soundproof studio.
Infants with delayed diagnoses and treatment for hearing loss would face problems in language comprehension of up to 4 year.
​
​
Unidentified hearing loss has a potential cost of over $750 billion worldwide.
​
Over 90% of the 32 million children suffering from hearing loss are from developing countries.
​
< 10% of infants in low-resource settings receive screening
​
Traditional screening device are expensive, costing $2,500 to $25,000
By the Numbers
Our Solution
OtoScreen is a low-cost, smartphone-based hearing screening device for the accurate identification of pediatric hearing loss in developing countries. Our device uniquely uses bone conduction to address the problems in traditional hearing tests.
Together, we...
-
Enable large scale screening of infants in hospitals
-
Reduce demand for limited number of trained personnel.
-
Reach patients outside of traditional healthcare settings
-
Allow testing in noisier environments
-
Empower community health workers
-
Improve language development and access to education
-
Enable better long term economic and social prospects